
Endeavour Vision is a venture capital and growth equity firm based in Geneva, Switzerland, focused on transformative healthcare technologies including medical devices and digital health. The firm partners with commercial-stage medtech and digital health companies in Europe and North America.
55% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Average disclosed round size is $62.7M (across 40 rounds with reported amounts).
Portfolio
33
Fund Size
$375M
Top Stage
Series C
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
51 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series E | $120M | Jun 2026 | |
| VVentureMed Group | Series C | $28M | Oct 2025 |
| Unknown | — | Jan 2025 | |
| Series E | $65M | Mar 2024 | |
| Unknown | $196M | Jan 2024 | |
| Series E | $85M | Jan 2024 | |
| Series C | $30M | Sep 2023 | |
| Series C | $30M | Sep 2023 | |
| Series G | $50M | Apr 2023 | |
| Bridge | — | Jan 2023 | |
| Unknown | $30M | Jan 2023 | |
| Series D | $60M | Oct 2022 | |
| Series C | $115M | Apr 2022 | |
| Series D | $60M | Jan 2022 | |
| Series A | — | Dec 2021 | |
| Series D | $102M | Sep 2021 | |
| Series C | — | May 2021 | |
| Bridge | $81M | Mar 2021 | |
| Series A | — | Jan 2021 | |
| Series A | $18.6M | Jan 2021 | |
| Series D | $102M | Jan 2021 | |
| Series D | $70M | Oct 2020 | |
| Series F | $110M | Oct 2020 | |
| Series C | $98M | Sep 2020 | |
| Series C | $55M | Sep 2020 |
Page 1 of 3
Top Co-Investors
Longitude Capital10 shared
Lightstone Ventures6 shared
Morgenthaler Ventures6 shared
Novo Capital6 shared
New Enterprise Associates5 shared
Canaan Partners5 shared
Ally Bridge Group5 shared
Pura Vida Investments5 shared
Kaiser Permanente Ventures5 shared
Decheng Capital5 shared
Baird5 shared
cultivate(MD)5 shared
Bluestem Capital Company5 shared
Aperture Venture Partners4 shared
Silicon Valley Bank4 shared
Emergent Medical Partners3 shared
venBio3 shared
RTW Investments, LP3 shared
Soleus Capital3 shared
Last updated: 20 October 2026